Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026)
Koninklijke Philips (PHG) recorded quarterly Net Income towards Common Stockholders of $187319.3 in Q1 2026, down 60.75% quarter-over-quarter from $477257.8 in Q4 2025, and up 122.6% on a YoY basis from $84150.8 in Q1 2025.
Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Koninklijke Philips' Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $187319.3 for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 122.6% year-over-year to $187319.3; the TTM figure through Mar 2026 stood at $1.2 million (up 175.26% YoY), while the FY2025 annual figure was $1.0 billion, up 278654.97% from the prior year.
- Net Income towards Common Stockholders was $187319.3 for Q1 2026 at Koninklijke Philips, down from $477257.8 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $506137.2 in Q2 2024 to a low of -$1.5 million in Q3 2022.
- Historically, Net Income towards Common Stockholders has averaged -$145286.9 across 5 years, with a median of $76224.7 in 2023.
- The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders tumbled 495.44% in 2022, then jumped 564.01% in 2024.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$112227.2 in 2022, then tumbled by 369.77% to -$527210.6 in 2023, then gained by 29.06% to -$374008.4 in 2024, then jumped by 227.61% to $477257.8 in 2025, then plunged by 60.75% to $187319.3 in 2026.
- The last three Net Income towards Common Stockholders figures came in at $187319.3 (Q1 2026), $477257.8 (Q4 2025), and $222120.5 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.04 Bn | 16.63 Bn | 1.51 Bn | 238.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187,319.30 |
| Dec 31, 2025 | 477,257.84 |
| Sep 30, 2025 | 222,120.47 |
| Jun 30, 2025 | 282,989.92 |
| Mar 31, 2025 | 84,150.76 |
| Dec 31, 2024 | -374,008.39 |
| Sep 30, 2024 | 208,661.71 |
| Jun 30, 2024 | 506,137.16 |
| Mar 31, 2024 | -1.16 Mn |
| Dec 31, 2023 | -527,210.56 |
| Sep 30, 2023 | 97,973.14 |
| Jun 30, 2023 | 76,224.71 |
| Mar 31, 2023 | -772,806.11 |
| Dec 31, 2022 | -112,227.21 |
| Sep 30, 2022 | -1.45 Mn |
| Jun 30, 2022 | -21,341.13 |
| Mar 31, 2022 | -190,797.41 |
| Dec 31, 2021 | 205,914.77 |
| Sep 30, 2021 | 3.84 Mn |
| Jun 30, 2021 | 204,726.14 |